113 related articles for article (PubMed ID: 21790228)
21. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
[TBL] [Abstract][Full Text] [Related]
22. Expression profile of microrna-145 in urothelial bladder cancer.
Dip N; Reis ST; Srougi M; Dall'Oglio MF; Leite KR
Int Braz J Urol; 2013; 39(1):95-101; discussion 102. PubMed ID: 23489501
[TBL] [Abstract][Full Text] [Related]
23. Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.
Dyrskjøt L; Ostenfeld MS; Bramsen JB; Silahtaroglu AN; Lamy P; Ramanathan R; Fristrup N; Jensen JL; Andersen CL; Zieger K; Kauppinen S; Ulhøi BP; Kjems J; Borre M; Orntoft TF
Cancer Res; 2009 Jun; 69(11):4851-60. PubMed ID: 19487295
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression.
Fei X; Qi M; Wu B; Song Y; Wang Y; Li T
FEBS Lett; 2012 Feb; 586(4):392-7. PubMed ID: 22265971
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1.
Peng Y; Dong W; Lin TX; Zhong GZ; Liao B; Wang B; Gu P; Huang L; Xie Y; Lu FD; Chen X; Xie WB; He W; Wu SX; Huang J
Oncotarget; 2015 Jun; 6(18):16043-58. PubMed ID: 25965824
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.
Lee MS; Lee J; Kim JH; Kim WT; Kim WJ; Ahn H; Park J
Oncotarget; 2015 Nov; 6(37):40370-84. PubMed ID: 26430961
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer.
Zhou Y; Wu D; Tao J; Qu P; Zhou Z; Hou J
Scand J Urol; 2013 Oct; 47(5):423-32. PubMed ID: 23206218
[TBL] [Abstract][Full Text] [Related]
28. Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1.
Kim IY; Lee DH; Lee DK; Kim WJ; Kim MM; Morton RA; Lerner SP; Kim SJ
Cancer Res; 2004 Oct; 64(20):7355-60. PubMed ID: 15492256
[TBL] [Abstract][Full Text] [Related]
29. Can increased expression of miR-Let-7c reduce the transition potential of high-grade urothelial carcinoma?
da Silva Gomes PR; Candido P; Ghazarian V; Camargo JA; Guimarães VR; Gonçalves GL; Romão P; Silva IA; Srougi M; Nahas WC; Leite KR; Reis ST; Pimenta R; Viana NI
Mol Biol Rep; 2021 Dec; 48(12):7947-7952. PubMed ID: 34708341
[TBL] [Abstract][Full Text] [Related]
30. miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT.
Zeng T; Peng L; Chao C; Fu B; Wang G; Wang Y; Zhu X
Int J Clin Exp Pathol; 2014; 7(11):7653-62. PubMed ID: 25550801
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of flotillin-1 is involved in proliferation and recurrence of bladder transitional cell carcinoma.
Guan Y; Song H; Zhang G; Ai X
Oncol Rep; 2014 Aug; 32(2):748-54. PubMed ID: 24890092
[TBL] [Abstract][Full Text] [Related]
32. miR-221/222 cluster expression improves clinical stratification of non-muscle invasive bladder cancer (TaT1) patients' risk for short-term relapse and progression.
Tsikrika FD; Avgeris M; Levis PK; Tokas T; Stravodimos K; Scorilas A
Genes Chromosomes Cancer; 2018 Mar; 57(3):150-161. PubMed ID: 29181884
[TBL] [Abstract][Full Text] [Related]
33. Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas.
Kömhoff M; Guan Y; Shappell HW; Davis L; Jack G; Shyr Y; Koch MO; Shappell SB; Breyer MD
Am J Pathol; 2000 Jul; 157(1):29-35. PubMed ID: 10880372
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44.
Yu G; Yao W; Xiao W; Li H; Xu H; Lang B
J Exp Clin Cancer Res; 2014 Dec; 33(1):779. PubMed ID: 25551284
[TBL] [Abstract][Full Text] [Related]
35. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
[TBL] [Abstract][Full Text] [Related]
36. Relapse and Survival in Bladder Cancer Patients Undergoing microRNA-129 and microRNA-145 Assays.
ELfieky MMM; Abd El Rahman M; Fayed AM; Haleem Al-Qaim Z; Khalid Aldhalmi A; Ae Badr E; Abdel Aziz A; Ibrahim GMA
Asian Pac J Cancer Prev; 2024 Jun; 25(6):2113-2121. PubMed ID: 38918674
[TBL] [Abstract][Full Text] [Related]
37. Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up.
Bartoletti R; Cai T; Nesi G; Sardi I; Rizzo M
Oncol Rep; 2005 Jul; 14(1):251-5. PubMed ID: 15944797
[TBL] [Abstract][Full Text] [Related]
38. microRNA-145 promotes differentiation in human urothelial carcinoma through down-regulation of syndecan-1.
Fujii T; Shimada K; Tatsumi Y; Hatakeyama K; Obayashi C; Fujimoto K; Konishi N
BMC Cancer; 2015 Oct; 15():818. PubMed ID: 26514209
[TBL] [Abstract][Full Text] [Related]
39. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.
Khella HW; Bakhet M; Allo G; Jewett MA; Girgis AH; Latif A; Girgis H; Von Both I; Bjarnason GA; Yousef GM
Carcinogenesis; 2013 Oct; 34(10):2231-9. PubMed ID: 23715501
[TBL] [Abstract][Full Text] [Related]
40. miR-26b is downregulated in human tongue squamous cell carcinoma and regulates cell proliferation and metastasis through a COX-2-dependent mechanism.
Cao J; Guo T; Dong Q; Zhang J; Li Y
Oncol Rep; 2015 Feb; 33(2):974-80. PubMed ID: 25483152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
